Journals / Çocuk Acil ve Yoğun Bakım Dergisi / 2016 / Cilt: 3 - Sayı: 2

The Probable Effect of Ketamine on Ceasing from the Mechanical Ventilation

Non-Ketotik Hiperglisinemide Mekanik Ventilasyondan Ayırmada Ketamin Etkin mi?

Pages
103–105
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case gives us an idea about the efficiency of ketamine in ceasing NCH patients from mechanical ventilation at early stages of disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Non-ketotic hyperglycinemia (NCH) is a life-threatening autosomal recessive hereditary metabolic disease characterized by accumulation of a large amount of glycine in serum and cerebrospinal fluids.
📊
Key Findings & Data:A 3-month-old girl was referred to our intensive care unit due to poor feeding, respiratory failure and refractory seizures.
💡
Conclusion & Impact:This case gives us an idea about the efficiency of ketamine in ceasing NCH patients from mechanical ventilation at early stages of disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Non-ketotic hyperglycinemia (NCH) is a life-threatening autosomal recessive hereditary metabolic disease characterized by accumulation of a large amount of glycine in serum and cerebrospinal fluids. A 3-month-old girl was referred to our intensive care unit due to poor feeding, respiratory failure and refractory seizures. Physical examination revealed poor general condition, hypotony, lethargia and quite shallow breathing. Her complete blood count, peripheral blood smear, liver and kidney function tests, serum electrolytes, blood gases, C-reactive protein, procalcitonin, ammonia and lactate levels were within the normal ranges. Her tandem mass and urine organic acid analyses were also normal. Blood and cerebrospinal fluid cultures were sterile. A suppression-burst pattern (modified hypsarrhythmia) was detected in electroencephalographic evaluation. The cerebrospinal fluid glycine level was elevated more than 10 folds and the cerebrospinal fluid glycine/plasma glycine ratio was 0.15. According to these laboratory findings, she was diagnosed with NCH and dextromethorphan and sodium benzoate therapies were initiated. Ventilatory support was provided due to respiratory failure. She was followed by the Synchronized intermittent mandatory ventilation + pressure support mode, and ketamine (2 mg/kg, iv) therapy was initiated. At the 7th day of this therapy, there was no need for mechanical ventilation anymore. This case gives us an idea about the efficiency of ketamine in ceasing NCH patients from mechanical ventilation at early stages of disease.

Özet

Non-ketotik hiperglisinemi (NKH) otozomal resesif geçiş gösteren serumda ve özellikle beyin omurilik sıvısında glisinin aşırı birikimi ile karakterize nadir görülen, yaşamı tehdit eden doğuştan bir metabolik hastalıktır. Üç aylık kız çocuğu emmeme, solunum yetmezliği ve sık tekrarlayan nöbet geçirme yakınmalarıyla yoğun bakım ünitesine kabul edildi. Fizik muayenesinde genel durumu kötü, hipotonik, letarjik, solunumu oldukça yüzeyseldi. Laboratuvar incelemelerinde kan sayımı, periferik yayma, karaciğer ve böbrek işlev testleri, serum elektrolitleri, kan gazı, C-reaktif protein, prokalsitonin, amonyak, laktat değerleri normal sınırlardaydı. Kan ve beyin omurilik sıvısı kültürlerinde üreme olmadı. Tandem mass ve idrar organik asit incelemesi normaldi. Elektroensefalografide burst süpresyon paterni (modifiye hipsaritmi) görünümü izlendi. Beyin omurilik sıvısında glisin düzeyi 10 kattan fazla artmış, beyin omurilik sıvısında glisin düzeyinin plazma glisine oranı 0,15 idi. Bu bulgularla non-ketotik hiperglisinemi tanısı konularak dekstrometorfan ve sodyum benzoat tedavisi başlandı. Apneik nöbetleri kontrol altına alınamayan solunum yetmezliği gelişen hasta mekanik ventilatör desteğine alındı. Senkronize aralıklı zorunlu ventilasyon + basınç desteği moduyla takip edilen hastanın tedavisine ketamin (2 mg/kg, iv) eklendi. Mekanik ventilasyon ihtiyacı yedinci günde ortadan kalktı. NKH tanısı konulan ve solunum desteğine ihtiyaç gösteren hastalarda ketamin tedavisi mekanik ventilatörden erken dönemde ayırmada yardımcı olabilir.

🔖

Cite This Article

DAVUTOĞLU, M., KILIÇ, Z., DALKIRAN, T., ÇOBAN, Y., KARABEL, N., ÇETİNKAYA, A. (2016). The Probable Effect of Ketamine on Ceasing from the Mechanical Ventilation. Çocuk Acil ve Yoğun Bakım Dergisi, Cilt: 3 - Sayı: 2, 103–105. https://ajindex.com/articles/160821

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Swanson MA, Coughlin CR Jr, Scharer GH, Szerlong HJ, Bjoraker KJ, et al. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol. 2015;78:606-18.
  2. Applegarth DA, Toone JR. Nonketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis. Mol Genet Metab. 2001;74:139-46.
  3. Hamosh A, Johnston MV. Nonketotic hyperglycinemia. In: Scriver C, Beaudet A, Sly W, Valle D (eds). The metabolic and molecular bases of inherited disease. New York, McGraw- Hill; 2001: 2065-78.
  4. Toone JR, Applegarth DA, Coulter-Mackie MB, James ER. Biochemical and molecular investigations of patients with nonketotic hyperglycinemia. Mol Genet Metab. 2000;70:116-21.
  5. Kure S, Kato K, Dinopoulos A, Gail C, deGrauw TJ, et al. Comprehensive mutation analysis of GLDC, AMT and GCSH in nonketotic hyperglycinemia. Hum Mutat. 2006;27:343-52.
  6. Hennermann JB, Berger JM, Grieben U, Scharer G, Van Hove JL. Prediction of long-term outcome in glycine encephalopathy: a clinical survey. J Inherit Metab Dis. 2012;35:253-61.
  7. Rossi S, Daniele I, Bastrenta P, Mastrangelo M, Lista G. Early myoclonic encephalopathy and nonketotic hyperglycinemia. Pediatr Neurol. 2009;41:371-4.
  8. Bjoraker KJ, Swanson MA, Coughlin CR, Christodoulou J, Tan ES, et al. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia. J Pediatr. 2016;170:234-9.
  9. Chien YH, Hsu CC, Huang A, Chou SP, Lu FL, et al. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high- dose sodium benzoate and dextromethorphan. J Child Neurol. 2004;19:39-42.
  10. Suzuki Y, Kure S, Oota M, Hino H, Fukuda M. Nonketotic hyperglycinemia: proposal of a diagnostic and treatment strategy. Pediatr Neurol. 2010;43:221-4.
  11. Hoover-Fong JE, Shah S, Van Hove JL, Applegarth D, Toone J, et al. Natural history of nonketotic hyperglycinemia in 65 patients. Neurology. 2004;63:1847-53.